ATE142627T1 - Methode zur verbesserung des schlafes - Google Patents

Methode zur verbesserung des schlafes

Info

Publication number
ATE142627T1
ATE142627T1 AT88200587T AT88200587T ATE142627T1 AT E142627 T1 ATE142627 T1 AT E142627T1 AT 88200587 T AT88200587 T AT 88200587T AT 88200587 T AT88200587 T AT 88200587T AT E142627 T1 ATE142627 T1 AT E142627T1
Authority
AT
Austria
Prior art keywords
6alkyl
aminocarbonyl
optionally substituted
hydroxyc1
chem
Prior art date
Application number
AT88200587T
Other languages
English (en)
Inventor
Daele Georges Henri Paul Van
Freddy Francois Vlaeminck
Marc Gustaaf Celine Verdonck
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE142627T1 publication Critical patent/ATE142627T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Photolithography (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
AT88200587T 1987-04-01 1988-03-29 Methode zur verbesserung des schlafes ATE142627T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3412987A 1987-04-01 1987-04-01

Publications (1)

Publication Number Publication Date
ATE142627T1 true ATE142627T1 (de) 1996-09-15

Family

ID=21874492

Family Applications (2)

Application Number Title Priority Date Filing Date
AT88200587T ATE142627T1 (de) 1987-04-01 1988-03-29 Methode zur verbesserung des schlafes
AT96200236T ATE207474T1 (de) 1987-04-01 1988-03-29 Schlafverbesserungsmittel

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT96200236T ATE207474T1 (de) 1987-04-01 1988-03-29 Schlafverbesserungsmittel

Country Status (21)

Country Link
EP (2) EP0727421B1 (de)
JP (1) JP2574377B2 (de)
KR (1) KR960016539B1 (de)
AT (2) ATE142627T1 (de)
AU (1) AU609790B2 (de)
CA (1) CA1315790C (de)
DE (2) DE3856501T2 (de)
DK (1) DK174878B1 (de)
ES (2) ES2091183T3 (de)
FI (1) FI97617C (de)
GR (1) GR3020983T3 (de)
HK (1) HK1006020A1 (de)
HU (2) HUT57740A (de)
IE (1) IE81057B1 (de)
IL (1) IL85919A (de)
NO (1) NO178660C (de)
NZ (1) NZ223847A (de)
PH (1) PH25507A (de)
PT (1) PT87118B (de)
RU (1) RU2014328C1 (de)
ZA (1) ZA882352B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840896A (en) * 1989-11-22 1998-11-24 Janssen Pharmaceutica, N.V. Method of preventing or limiting reperfusion damage
RU2093156C1 (ru) * 1989-11-22 1997-10-20 Жансен Фармасетика Н.В. L-(-)-2-(аминокарбонил)-n-(4-амино-2,6-дихлорфенил-4[5,5-бис(4-фторфенил)пентил]-1-пиперазинацетамид, его фармацевтически приемлемая кислотно-аддитивная соль или гидрат, способ его получения и средство для хранения сердца донора
JP2660086B2 (ja) * 1990-07-03 1997-10-08 明治製菓株式会社 脳及び心機能障害改善剤
US5276035A (en) * 1990-07-26 1994-01-04 Novo Nordisk A/S 1,4-disubstituted piperazines
NZ240863A (en) * 1991-09-11 1995-04-27 Mcneilab Inc Substituted 4-aryl piperidine and 4-aryl piperazine derivatives, preparation and pharmaceutical compositions thereof
SE9202266D0 (sv) * 1992-07-31 1992-07-31 Kabi Pharmacia Ab Novel piperazine carboxamides
ATE174913T1 (de) * 1992-07-31 1999-01-15 Bristol Myers Squibb Co Diphenyl oxazole-, thiazole- und imidazole- derivate als inhibitoren der wiederaufnahme des adenosins
EP0756593B1 (de) * 1994-04-20 2000-09-20 Lonza Ag Verfahren zur herstellung von 2-piperazincarbonsäurederivaten
CA2234342A1 (en) * 1997-04-10 1998-10-10 Kyowa Hakko Kogyo Co., Ltd. Pancreatitis remedy
WO1998057643A1 (en) * 1997-06-16 1998-12-23 Janssen Pharmaceutica N.V. Use of draflazine-analogues for treating pain
UA89503C2 (uk) * 2004-09-13 2010-02-10 Х. Луннбек А/С Заміщені похідні аніліну
WO2006074025A1 (en) 2004-12-30 2006-07-13 Janssen Pharmaceutica N.V. Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase
UA108233C2 (uk) 2010-05-03 2015-04-10 Модулятори активності гідролази амідів жирних кислот
CN110511220B (zh) * 2018-05-22 2022-04-01 上海挚盟医药科技有限公司 作为钾通道调节剂的对二氨基苯衍生物、其制备方法及其在医药上的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1795375A1 (de) * 1968-09-21 1972-01-05 Boehringer Mannheim Gmbh Basische AEther und Verfahren zur Herstellung derselben
US4766125A (en) * 1981-06-23 1988-08-23 Janssen Pharmaceutica N.V. N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia

Also Published As

Publication number Publication date
EP0285219A2 (de) 1988-10-05
HU211129A9 (en) 1995-10-30
RU2014328C1 (ru) 1994-06-15
NO881407L (no) 1988-10-03
JPS63290869A (ja) 1988-11-28
FI97617C (fi) 1997-01-27
EP0285219A3 (de) 1991-07-03
KR880012566A (ko) 1988-11-28
FI881525A7 (fi) 1988-10-02
ES2167510T3 (es) 2002-05-16
DE3855520T2 (de) 1997-02-06
IE81057B1 (en) 1999-12-29
DK179788A (da) 1988-10-02
GR3020983T3 (en) 1996-12-31
ES2091183T3 (es) 1996-11-01
CA1315790C (en) 1993-04-06
IL85919A (en) 1992-12-01
PT87118A (pt) 1988-04-01
DK179788D0 (da) 1988-03-30
PT87118B (pt) 1992-07-31
PH25507A (en) 1991-07-24
JP2574377B2 (ja) 1997-01-22
ZA882352B (en) 1989-12-27
AU1384788A (en) 1988-10-06
NO881407D0 (no) 1988-03-29
FI881525A0 (fi) 1988-03-31
IL85919A0 (en) 1988-09-30
EP0285219B1 (de) 1996-09-11
DE3855520D1 (de) 1996-10-17
EP0727421A1 (de) 1996-08-21
ATE207474T1 (de) 2001-11-15
DE3856501D1 (de) 2001-11-29
EP0727421B1 (de) 2001-10-24
NZ223847A (en) 1989-12-21
NO178660C (no) 1996-05-08
DK174878B1 (da) 2004-01-12
IE880989L (en) 1988-10-01
NO178660B (no) 1996-01-29
HK1006020A1 (en) 1999-02-05
AU609790B2 (en) 1991-05-09
DE3856501T2 (de) 2004-04-29
HUT57740A (en) 1991-12-30
FI97617B (fi) 1996-10-15
KR960016539B1 (ko) 1996-12-14

Similar Documents

Publication Publication Date Title
DE3176010D1 (en) Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids, salts thereof, pharmaceutical compositions containing the derivatives or salts, and the production of the same
HUT46708A (en) Process for producing heterocyclic ketones and pharmaceutical compositions containing them as active components
HUT58322A (en) Process for producing new n-(3-hydroxy-4-piperidinyl)-dihydro-benzofurane-, -dihydro-2h-penzopyrane- and -dihydro-benzodioxine-carboxamide derivatives and pharmaceutical compositions containing them
DE3855520D1 (de) Methode zur Verbesserung des Schlafes
HUT50316A (en) Process for production of 1-phenyl-3-naphthyl-oxy-propanamines and pharmaceutical preparations containing them
HUT48589A (en) Process for production of new derivatives of substituated n-/1-hydroxi-4-piperidinil/-benzamid
HU9200134D0 (en) Process for the production of /6s/- and /6r/-tetrahydropholic acid
HUT40101A (en) Process for producing quinolin-carboxylic acid derivatives and pharmaceutical compositions containing them as active agents
IE890177L (en) Piperidinyl derivatives
HU891462D0 (en) Process for the preparation of novel compounds
JPS6442472A (en) Quinazoline derivative, production thereof and brain function disorder improving agent containing said derivative as active ingredient
DK0398427T3 (da) Antirhinovirale pyridazinaminer
FI894125A0 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisen 3-piperidinyyli-indatsolin valmistamiseksi
DK158513C (da) N-(substitueret phenyl)-n'-pyridinylurinstoffer, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
JPS5673047A (en) Decaprenylamine derivative
EP0323604A3 (de) Dihydropyridin-Verbindung zur Verbesserung der Adernausdehnung und Hemmung der Herzhypertrophie

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time